Avigen is investigating the use of AAV vectors to deliver the factor IX gene for the treatment of hemophilia B and the factor VIII gene for hemophilia A. Preclinical efficacy and safety studies in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback